Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome
Author:
Affiliation:
1. Center for Drug Evaluation and Research; Food and Drug Administration; 10903 New Hampshire Avenue; Silver Spring; MD; 20993; USA
Publisher
Wiley
Subject
Toxicology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jat.2813/fullpdf
Reference51 articles.
1. Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats;Abe;Am. J. Respiratory Cell and Mol. Biology,2011
2. Sunitinib, a receptor tyrosine kinase inhibitor, increases blood pressure in rats without associated changes in cardiac structure and function;Blasi;Cardiovasc. Ther.,2011
3. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes;Braam;Stem Cell Res.,2010
4. Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics;Chen;Circulation,2008
5. Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics;Cheng;Circ. Res.,2010
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice;Apoptosis;2023-11-09
2. Kinase Inhibitors Involved in the Regulation of Autophagy: Molecular Concepts and Clinical Implications;Current Medicinal Chemistry;2023-04
3. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway;Bioengineered;2021-12-29
4. Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission;Frontiers in Cardiovascular Medicine;2021-09-03
5. Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies;Expert Review of Clinical Pharmacology;2021-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3